drugset / Trial / NCT01556100

Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression

NCT01556100 ↗

Phase 2 Completed 40 enrolled Chang Gung Memorial Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

A total 40 PD subjects will be included in this study. PD subjects between 20 and 80 years of age may be eligible for this study. Candidates are screened with a medical history and physical examination, and blood test.

Timeline

Start
2011-11
Primary completion
2015-05
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-DTBZ AV-133 Diagnostic / imaging agent — —

Indications